$ARIA Headlines Hewlett-Packard, a cyclical green light

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2013 at 9:59 AM

$ARIA Headlines

Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy

7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
3 Best Performing Stocks of November in Focus - Analyst Blog 5:34 p.m. Dec. 2, 2013 - Zacks.com
Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA) 7:52 a.m. Dec. 2, 2013 - TheStreet.com
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Nov. 29, 2013 - benzinga.com
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
Wednesday’s Biggest Stock Losers: BLOX, BRLI and More 5:10 a.m. Nov. 27, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) In A Perilous Reversal 11:50 a.m. Nov. 26, 2013 - TheStreet.com
Nuance and ARIAD Are Volume Movers for Very Different Reasons 11:24 a.m. Nov. 26, 2013 - 247WallSt.com
Ariad Pharma Appears Cheap Despite Reduced Opportunity 9:19 a.m. Nov. 26, 2013 - Seeking Alpha
Cramer's Lightning Round - What Happened With Ariad Was Jarring (11/25/13) 6:05 a.m. Nov. 26, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Splunk 6:00 a.m. Nov. 26, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market 8:25 p.m. Nov. 25, 2013 - TheStreet.com
Continuation of ARIAD's Iclusig in EU - Analyst Blog 5:00 p.m. Nov. 25, 2013 - Zacks.com
Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000 3:57 p.m. Nov. 25, 2013 - benzinga.com
ARIAD Shares Skyrocketing With 11 Positive Estimate Revisions 1:35 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:27 p.m. Nov. 25, 2013 - TheStreet.com
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock 12:36 p.m. Nov. 25, 2013 - TheStreet.com
3 Monday Morning Biotech Movers 12:15 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet

UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE
Traders Buzz: Tesla Motors Inc, Sirius XM Radio, Microsoft Corporation, Ariad Pharmaceuticals 9:35 a.m. Dec. 2, 2013 - ACCESSWIRE
TrendingWallStreet.com Starts Volume Coverage on AAPL, IACH, ARIA, and JCP 12:45 a.m. Dec. 2, 2013 - ACCESSWIRE
Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
TrendingWallStreet.com Begins Market Coverage on NLY, VEND, ARIA, and FB 12:15 a.m. Nov. 27, 2013 - ACCESSWIRE
Must Watch Stocks: Ariad Pharmaceuticals, Hewlett-Packard Company, Camtek Ltd, Buka Ventures Inc 9:01 a.m. Nov. 26, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Analysis on BAC, NVGC, ARIA, and C 12:16 a.m. Nov. 26, 2013 - ACCESSWIRE
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 25, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Coverage on ARIA, TXCC, SFTBY, and TWC 1:38 a.m. Nov. 25, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. -- ARIA 3:32 p.m. Nov. 22, 2013 - GlobeNewswire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against ARIAD Pharmaceuticals, Inc. and Certain Officers - ARIA 8:00 a.m. Nov. 22, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...